Given the aim of identifying mild cognitive impairment is the early treatment of dementia, people with mild cognitive impairment due to anticholinergic drugs could be in the absurd situation of receiving pro-cholinergic drugs to counteract the effects of anticholinergic agents, according to the authors.
They suggest that doctors assess the current use of anticholinergic drugs in elderly people with mild cognitive impairment before considering treatment for dementia.
Edited (ANI)